Fig. 1: Current DLBCL classifiers do not discriminate early clinical failures. | Blood Cancer Journal

Fig. 1: Current DLBCL classifiers do not discriminate early clinical failures.

From: Multiomic analysis identifies a high-risk signature that predicts early clinical failure in DLBCL

Fig. 1

LymphGen (A), HMRN (B), and EcoTyper B Cell State (C) classification of ndDLBCL. Pie charts (upper panel) show distribution of cases for each classifier. Sankey plots (middle panel) show the distribution of EFS24 fail or achieve cases for each classifier. Kaplan−Meier analysis (lower panel) of EFS24 for each classifier, LymphGen P = 0.96, HMRN P = 0.98, and B Cell State P = 0.73.

Back to article page